CPH:SMSMED Cash Flow Statement

Financials in millions DKK. Fiscal year is October - September.

Millions DKK. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Income	-6.82	1.79	13.75	16.63	14.74	10.87
Depreciation & Amortization	9.79	8.73	7.26	4.46	0.61	0.02
Other Adjustments	-3.12	-1.57	-3.68	-0.58	-0.02	-0.33
Changes in Income Taxes Payable	-1.51	-1.2	-7.03	-2.49	-0.17	-2.17
Changes in Other Operating Activities	-3.03	-21.16	-6.91	-26.38	-25.73	-4.37
Operating Cash Flow	-4.69	-13.41	3.39	-8.37	-10.57	4.02
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-18.93	-20.81	-18.47	-40.82	-13.76	0
Sale of Property, Plant & Equipment	0.32	1.28	7.64	1.24	0	-
Purchases of Investments	-0.33	-0.31	-0.3	-0.29	-0.01	-0.27
Investing Cash Flow	-18.95	-19.84	-11.13	-39.87	-13.77	-0.27
Long-Term Debt Issued	18.12	38.04	21.67	22.74	0	-
Long-Term Debt Repaid	-13.88	-13.56	-3.76	-1.59	0	-
Net Long-Term Debt Issued (Repaid)	4.24	24.48	17.91	21.14	0	-
Issuance of Common Stock	0.18	0.25	0.24	0.07	30	19.46
Net Common Stock Issued (Repurchased)	0.18	0.25	0.24	0.07	30	19.46
Common Dividends Paid	-	-	-	-	-	-4.52
Other Financing Activities	-	-	-	-0.03	-3.3	-3.87
Financing Cash Flow	30.98	24.72	18.15	21.19	26.7	11.07
Foreign Exchange Rate Adjustments	-0.17	-0.12	-0.07	-0.26	0	-
Net Cash Flow	7.34	-8.54	10.42	-27.05	2.36	14.83
Free Cash Flow	-23.62	-34.22	-15.08	-49.19	-24.33	4.02
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-10.99%	-13.94%	-6.65%	-25.73%	-22.01%	5.62%
Free Cash Flow Per Share	-0.85	-1.24	-0.55	-1.80	-0.91	1.22
Levered Free Cash Flow	-17.09	-9.93	0.55	-31.87	-27.68	1.64
Unlevered Free Cash Flow	-18.93	-34.22	-14.51	-52.37	-27.65	1.9